Objective: To evaluate macular retinal sensitivity and its role in foveal function among diabetic and non-diabetic patients with normal acuity. Material and Method: Participants in this cross-sectional, prospective, observational, descriptive research with and without type 2 diabetes mellitus did not exhibit any abnormalities in their eyes. The study, which was conducted at the University of Lahore Teaching Hospital from June 15, 2023, to June 30, 2024, had 33 diabetes participants and 30 non-diabetic subjects who were age matched. The subjects, who might be of any gender and ages, exhibited stable fixation, corrected visual acuity of 20/20, and no ocular media opacities. Participants were chosen by non-randomized sequential sampling. Results: The evaluation consisted of 80 eyes from 63 people, ranging in age from 45 to 75 years (mean, 54.2 ± S.E. 0.97); 55 eyes (68.75%) belonged to females. The tests were deemed credible since the mean fixation losses were 0.4 ± 0.09 and the test length ranged from 5.43 to 7.04 min (mean 6.05 ± 0.08). Group 1 (Table 1) consisted of forty eyes from 30 participants without diabetes; their ages ranged from 45 to 75 years old (mean 52.7 ± 2.4). Fifity five eyes (68.75%%) belonged to females, and their foveal sensitivity ranged from 28 to 40 dB (mean 35.78 ± 0.6). In the second group, 25 eyes (62.5%) belonged to females and 40 eyes (mean 55.8 ± 1.4) of 33 people with diabetes but no retinopathy were assessed. The participants ranged in age from 45 to 75 years. The foveal sensitivity measured was 33.88 ± 0.7dB. Foveal sensitivity and perimetry points for the two groups are shown in Tables 2-4. Table 3 shows that group 1 had greater mean sensitivity than group 2 at particular stages (6, 9, 12, and 15). Table 2 shows bivariate correlations. Due to group 2's lower sensitivity in decibels, this indicates that group 2 needs a higher brightness (Asb) in order to perceive stimuli. According to Table 4, there was a 41 percent difference in proportion between groups at point 15, although point 7 stayed the same. At point 15, focal sensitivity revealed a correlation of 35%. Conclusion: Diabetics have reduced macular and foveal sensitivity than non diabetics even eyesight is normal. This decline may indicate early functional retinal impairment that occurs prior to noticeable vision loss. Point 1 significantly enhanced foveal sensitivity in people with diabetes.The findings emphasize the need of assessing macular sensitivity in order to detect retinal damage in diabetic patients early on. These findings provide possible methods for monitoring and detecting diabetic retinopathy.